MSD launches India's first gender-neutral Human Papillomavirus Vaccine "Gardasil-9"

Category : Miscellaneous Published on: October 01 2021

Share on facebook

· MSD Pharmaceuticals has launched India's first gender-neutral Human Papillomavirus (HPV) vaccine to reduce the HPV-related disease burden and cancer caused by the virus in Indian women, girls and boys.

· It is the only US Food and Drug Administration (USFDA) approved HPV vaccine that will help reduce HPV-related diseases and cancers in India.

· "Gardasil-9" is a three-dose nanovalent (9-valent) human papillomavirus or HPV vaccine that helps to reduce HPV-related diseases and cancers.

Important facts

About USFDA

· The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services.

· Founded: 30 June 1906

· Founders: Theodore Roosevelt, Harvey Washington Wiley

· Headquarters: Silver Spring, Maryland

Feb 25

Feb 24

Feb 24

Feb 24

Feb 23

MSD launches India's first gender-neutral Human Papillomavirus Vaccine "Gardasil-9"

Recent Post's

Notification view all

Feb 25

Feb 24

Feb 24

Feb 24

Feb 23

MSD launches India's first gender-neutral Human Papillomavirus Vaccine "Gardasil-9"

Recent Post's

Notification
view all